Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2794

1.
2.

Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.

Westfall DE, Folpe AL, Paner GP, Oliva E, Goldstein L, Alsabeh R, Gown AM, Amin MB.

Am J Surg Pathol. 2009 Jan;33(1):99-105. doi: 10.1097/PAS.0b013e318180c899.

PMID:
18941404
3.

Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?

Buchumensky V, Klein A, Zemer R, Kessler OJ, Zimlichman S, Nissenkorn I.

J Urol. 1998 Dec;160(6 Pt 1):1971-4.

PMID:
9817302
4.

Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.

Guo CC, Fine SW, Epstein JI.

Am J Surg Pathol. 2006 Jul;30(7):883-91.

PMID:
16819332
5.

Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI.

Am J Surg Pathol. 2006 Dec;30(12):1502-12.

PMID:
17122505
7.

Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.

Klein A, Zemer R, Buchumensky V, Klaper R, Nissenkorn I.

Cancer. 1998 Jan 15;82(2):349-54.

PMID:
9445193
9.

Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.

Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C, Wang M, Cheng L.

Am J Surg Pathol. 2010 Mar;34(3):371-6. doi: 10.1097/PAS.0b013e3181cd385b.

PMID:
20139762
10.
11.

Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.

Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan GA, Quek ML, Ro JY, Amin MB.

Am J Surg Pathol. 2009 Jan;33(1):91-8. doi: 10.1097/PAS.0b013e3181804727.

PMID:
18936687
12.

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.

Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA.

Am J Clin Pathol. 2000 Mar;113(3):383-8.

13.

Discrimination of cell types in primary transitional cell carcinoma by monoclonal anti-cytokeratin antibodies.

Reedy EA, Colombo-Burke KL, Resau JH.

Pathobiology. 1990;58(6):304-11.

PMID:
1706601
14.

Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Morgan MB, Purohit C, Anglin TR.

Am J Dermatopathol. 2008 Jun;30(3):228-32. doi: 10.1097/DAD.0b013e31816de820.

PMID:
18496422
15.

Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.

Iczkowski KA, Shanks JH, Gadaleanu V, Cheng L, Jones EC, Neumann R, Nascimento AG, Bostwick DG.

Mod Pathol. 2001 Oct;14(10):1043-51.

16.

Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases.

Velazquez EF, Melamed J, Barreto JE, Aguero F, Cubilla AL.

Am J Surg Pathol. 2005 Sep;29(9):1152-8.

PMID:
16096403
17.

Atypia in inverted urothelial papillomas: pathology and prognostic significance.

Broussard JN, Tan PH, Epstein JI.

Hum Pathol. 2004 Dec;35(12):1499-504.

PMID:
15619209
20.
Items per page

Supplemental Content

Write to the Help Desk